Drugs / Homeo-GH
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01318330 | Nov 2010 → Dec 2011 | graft versus host disease | HomeoTherapy Co., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Homeo-GH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01318330 ↗ |
| Modality | Cell therapy | “ex-vivo cultured adult human clonal mesenchymal stem cells (cMSC) derived from human bone marrow” NCT01318330 ↗ |
| Route | Intravenous | “Clonal MSCs will be infused to acute or chronic GVHD patients via an intravenous injection” NCT01318330 ↗ |